Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
ViferaXS raises $13.6M for Phase II cancer immunotherapy trial in chronic lymphocytic leukemia
Dealroom.co1 min read
ViferaXS raises $13.6M for Phase II cancer immunotherapy trial in chronic lymphocytic leukemia Dealroom
Read the full article at Dealroom.coRelated coverage
AI & Society
How to build a cancer vaccine, and whether they will work this time
LessWrong · Jun 8, 2026
AI Products
Forbes Asia 100 To Watch 2026
forbes.com · Aug 24, 2026
AI Products
XtalPi Holdings Limited: XtalPi Holdings Announces 2026 Interim Results
finanznachrichten.de · Aug 19, 2026
Quantum Computing
News Archive 2026
Quantum Computing Report · Jul 25, 2026